Humana Inc. $HUM Shares Purchased by Czech National Bank

Key Points

• Czech National Bank increased its stake in Humana Inc. by 6.5%, holding 29,501 shares worth approximately $7.21 million at the end of the second quarter.
• Humana reported earnings of $6.27 per share for the last quarter, missing analysts’ expectations, but generated revenues of $32.39 billion, exceeding the forecast.
• The company announced a quarterly dividend of $0.885 per share, representing an annual yield of 1.3%, with a payout ratio of 27.17%.

Czech National Bank raised its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 6.5% during the second quarter, according to its most recent filing with the SEC. The firm owned 29,501 shares of the insurance provider's stock after purchasing an additional 1,792 shares during the period. Czech National Bank's holdings in Humana were worth $7,212,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of Humana by 8.9% during the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock valued at $3,697,222,000 after buying an additional 1,143,662 shares during the last quarter. AQR Capital Management LLC raised its stake in shares of Humana by 3,257.5% during the 1st quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider's stock worth $307,624,000 after acquiring an additional 1,127,973 shares in the last quarter. GAMMA Investing LLC boosted its stake in Humana by 40,881.1% in the first quarter. GAMMA Investing LLC now owns 781,099 shares of the insurance provider's stock valued at $2,066,790,000 after acquiring an additional 779,193 shares in the last quarter. Nuveen LLC purchased a new position in Humana in the first quarter worth $171,220,000. Finally, Dodge & Cox grew its holdings in Humana by 5.5% in the first quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider's stock worth $2,845,830,000 after purchasing an additional 557,175 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Analyst Upgrades and Downgrades

HUM has been the subject of several analyst reports. Wall Street Zen lowered Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Wells Fargo & Company reduced their target price on Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a research report on Thursday, August 14th. Sanford C. Bernstein increased their price target on Humana from $269.00 to $341.00 and gave the company an "outperform" rating in a research note on Friday, September 5th. Barclays boosted their price target on Humana from $275.00 to $315.00 and gave the stock an "equal weight" rating in a research note on Friday, September 5th. Finally, Piper Sandler cut their price objective on shares of Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a report on Thursday, July 31st. Seven research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $289.24.

Humana Trading Down 4.7%

Humana stock traded down $12.47 during trading on Friday, reaching $252.39. 4,954,304 shares of the company were exchanged, compared to its average volume of 1,678,064. The stock's 50 day simple moving average is $268.56 and its two-hundred day simple moving average is $257.29. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The company has a market capitalization of $30.35 billion, a P/E ratio of 19.37, a PEG ratio of 1.48 and a beta of 0.44. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $324.38.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The business had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company's revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. On average, equities research analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.4%. The ex-dividend date is Friday, September 26th. Humana's payout ratio is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.